Lisa Koenig, MD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Eye (ocular) cancers and conditions
- Eye (ocular) tumors
Get to Know Me
I am a board-certified ophthalmologist with additional training in ophthalmic oncology. I care for people with cancers of the eye as well as those whose vision has been affected by cancer or its treatment. I see patients at Memorial Hospital, the main hospital at Memorial Sloan Kettering Cancer Center (MSK), and the Rockefeller Outpatient Pavilion in New York City.
As a third-generation ophthalmologist, I developed an intuitive understanding from an early age that vision is a gift, not to be taken for granted. I’m honored to carry forward my family tradition of caring for sight.
For my patients, I strive to be a partner, helping them navigate the complexities of their illness. My goal is to not only address medical needs but also to recognize the emotional and practical challenges associated with conditions that may affect or threaten vision.
I am committed to working together with patients and their families, and also experts across different teams at MSK to make sure we deliver the best care.
Earlier in my career, I worked as a management consultant advising biopharmaceutical companies on drug development. This gave me an understanding of the complexities of our healthcare system. It also opened my eyes to the many daily challenges patients may face on their journey, and enhanced my ability to offer holistic support.
In my spare time, I enjoy playing tennis, reading fiction, and exploring New York City with my husband, daughter, and miniature goldendoodle.
I'm an ophthalmic (of-THAL-mik) oncologist, which is a cancer doctor with special training in eye cancers. This includes eye melanoma and retinoblastoma.
- Instructor
Conditions I Treat
- Eye (ocular) cancers and conditions
- Eye (ocular) tumors
Education
- MD, Weill Cornell Medical College
Residencies
- Ophthalmology, NewYork-Presbyterian/Weill Cornell Medicine
Fellowships
- Ophthalmic Oncology, Memorial Sloan Kettering Cancer Center
Board Certifications
- American Board of Ophthalmology
Awards and Honors
- Resident Research Award, Weill Cornell Medicine Department of Ophthalmology, NewYork-Presbyterian (2024)
- Resident Excellence Award, American Society of Cataract and Refractive Surgery (ASCRS) (2023)
- Phi Beta Kappa, Dartmouth College (2012)
- Magna cum laude, Dartmouth College (2012)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
TBD
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
- Gupta MP, Koenig LR, Doubrovina E, Hasan A, Dahi PB, O’Reilly RJ, Koehne G, Orlin A, Chan RVP, D’Amico DJ, Park SS, Burkholder BM, Kiss S. Ocular outcomes after treatment of cytomegalovirus retinitis using adoptive immunotherapy with cytomegalovirus-specific cytotoxic T lymphocytes. Ophthalmol Retina. 2021 Sep;5(9):838-849.
Visit PubMed for a full listing of Dr. Koenig’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Lisa Koenig discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].